Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized ...
Q1 2026
May 13, 2026
FY 2025
Mar 30, 2026
Q4 2025
Q3 2025
Nov 13, 2025
Q2 2025
Aug 12, 2025